Angaleshwari
Representative @Dhanvantari Clinical Research Solutions | Clinical Trial Operations | Expertise in NASH, OSA, Obesity, T2DM, PAD, HF ,NSCLC clinical studies
- Role
- Representative at Dhanvantari Clinical Research Solutions
- Location
- Mysuru, KA, IN
- LinkedIn followers
- 500 followers
About Angaleshwari
A PharmD graduate from The Tamil Nadu Dr. M.G.R. Medical University, I am currently pursuing a PhD in Neuro Immuno Pharmacology at JSS University. My academic journey has been centered around pharmacology, pharmacotherapeutics, and pharmacoeconomics, fostering a strong foundation for my career in clinical research and pharmaceutical sciences. As a Representative at Dhanvantari Clinical Research Solutions, I contribute to trial operations, regulatory adherence, and GCP compliance. My role involves site engagement, regulatory oversight, and supporting sponsors and CROs in meeting enrollment objectives while ensuring quality data aligned with ICH-GCP guidelines. I actively work on delivering trial presentations, educating site staff, and enhancing trial visibility through professional engagement and stakeholder feedback, driving excellence in clinical research.
Experience
Representative
Dhanvantari Clinical Research Solutions
Sep 2025 — Present · Karnataka, IN
Education
Chinmaya Vidyalaya
Higher secondary education, Bio maths
St. Pauls Public school fort kochi
SSC, School
Centre for experimental pharmacology and toxicology (CEPT) . JSS University. Mysore
Doctor of Philosophy - PhD, Neuro immuno pharmacology
Dr MGR Educational and Research Institute
Doctor of Pharmacy - PharmD, Pharmacology pharmacothrepeutics and pharmacoeconomics
2017 — 2023
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.